Author

Marie Parish

Observed name: Marie A. Parish

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Observed institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

OpenAlex ID: A5034860948

The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world.

2023 · Sakti Chakrabarti, Marie Parish, et al. · Journal of Clinical Oncology · 6

Severe enterocolitis with capecitabine (CAPE) is not a predictor of gastrointestinal (GI) toxicity with infusional 5-fluorouracil (5-FU)–based regimens: An institutional analysis.

2023 · Marie Parish, Ronald Cox, et al. · Journal of Clinical Oncology · 1

Impact of proton pump inhibitors on pathologic response rates following fluoropyrimidine‐based neoadjuvant chemotherapy in pancreatic cancer patients

2024 · Jessica A. Steadman, Ahmer Sultan, et al. · Journal of Surgical Oncology

Initial findings from the DREAM-GI national database: Assessing the efficacy and safety of neoadjuvant immunotherapy (NIT) in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) gastrointestinal (GI) cancer.

2024 · Sakti Chakrabarti, J. Eva Selfridge, et al. · Journal of Clinical Oncology

Works count: 4

Citation count: 7

H-index: 1

I10-index: